Form 4: Immuneering Corp Executive Harold Eugene Brakewood Acquires 3,900 Shares

Harold Eugene Brakewood, Chief Business Officer of Immuneering Corp, purchased 3,900 shares of Class A Common Stock at $2.568 per share on March 22, 2024.

Summary

• On March 22, 2024, Harold Eugene Brakewood, the Chief Business Officer of Immuneering Corp, acquired 3,900 shares of Class A Common Stock.
• The purchase price was $2.568 per share.
• Following the transaction, Mr. Brakewood directly owns 3,900 shares of Immuneering Corp.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a routine transaction by an executive. While insider buying can be seen as positive, it's a relatively small transaction and doesn't necessarily indicate a major shift in the company's prospects.

Positives

• An executive's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of the US financial markets and are required by the SEC to ensure transparency of insider transactions. They provide insights into the actions of company insiders, which can be informative for investors.

Stakeholder Impact

• The purchase could have a minor positive impact on shareholder sentiment.

Key Dates